Kapitalradar

Swiss capital increases, read from the official gazette and scored for financing rounds.

updated every weekdayrelease r10data as of 8 Oct 2026

↺ Try a rewind: Soverli AG on 24 Sep 2025, 83 days before the round was announced

Release evaluation · 7 Oct 2026 · does not rewind · rules + Claude: precision 2%–100% (n=17), recall 16/30 announced rounds · rules-only: precision 1%–99% (n=29), recall 18/30 announced rounds · Methodology

← Back to the feed

UMushroom AG

History from 23 Nov 2020

UID
CHE-354.687.178
Legal form
AG
Canton
ZH
Founded
23 Nov 2020
Amount raised
not in the SHAB
Lead investor
not in the SHAB
Nominal capital · CHFCHF 197k
49k98k148k197k3 Nov 2021 · CHF 141k6 Apr 2022 · CHF 143k6 Jul 2023 · CHF 167k10 May 2024 · CHF 185k18 Feb 2026 · CHF 197k20222023202420252026
  • shares

Record

  1. Company formed

    Founded 23 Nov 2020

    SHAB HR01-1005031928 ↗
  2. Capital increase

    Not assessed

    Paid in cash

    Nominal capital
    100’000 → 141’000
    Shares
    10’000’000 → 14’100’000
    New shares, % of post-step shares
    29.1% (4’100’000 new)

    Aktienkapital neu: CHF 141'000.00 [bisher: CHF 100'000.00]. Liberierung Aktienkapital neu: CHF 141'000.00 [bisher: CHF 100'000.00]. Aktien neu: 14'100'000 Namenaktien zu CHF 0.01 [bisher: 10'000'000 Namenaktien zu CHF 0.01].

    From the SHAB entry · German original, person names removed · not an official copy · full entry ↗
    SHAB HR02-1005325704 ↗
  3. Capital increase

    Not assessed

    Paid in cash

    Nominal capital
    141’000 → 142’690
    Shares
    14’100’000 → 14’269’000
    New shares, % of post-step shares
    1.2% (169’000 new)

    Aktienkapital neu: CHF 142'690.00 [bisher: CHF 141'000.00]. Liberierung Aktienkapital neu: CHF 142'690.00 [bisher: CHF 141'000.00]. Aktien neu: 14'269'000 Namenaktien zu CHF 0.01 [bisher: 14'100'000 Namenaktien zu CHF 0.01].

    From the SHAB entry · German original, person names removed · not an official copy · full entry ↗
    SHAB HR02-1005443946 ↗
  4. Capital increase

    Not assessed

    Paid in cash

    Nominal capital
    142’690 → 166’547.14
    Shares
    14’269’000 → 16’654’714
    New shares, % of post-step shares
    14.3% (2’385’714 new)

    Aktienkapital neu: CHF 166'547.14 [bisher: CHF 142'690.00]. Liberierung Aktienkapital neu: CHF 166'547.14 [bisher: CHF 142'690.00]. Aktien neu: 16'654'714 Namenaktien zu CHF 0.01 [bisher: 14'269'000 Namenaktien zu CHF 0.01].

    From the SHAB entry · German original, person names removed · not an official copy · full entry ↗
    SHAB HR02-1005788239 ↗
  5. Capital increase

    Not assessed

    Paid in cash

    Nominal capital
    166’547.14 → 185’102.68
    Shares
    16’654’714 → 18’510’268
    New shares, % of post-step shares
    10.0% (1’855’554 new)

    Aktienkapital neu: CHF 185'102.68 [bisher: CHF 166'547.14]. Liberierung Aktienkapital neu: CHF 185'102.68 [bisher: CHF 166'547.14]. Aktien neu: 18'510'268 Namenaktien zu CHF 0.01 [bisher: 16'654'714 Namenaktien zu CHF 0.01].

    From the SHAB entry · German original, person names removed · not an official copy · full entry ↗
    SHAB HR02-1006028629 ↗
  6. Capital increase

    Likely financing

    Paid in cash

    Nominal capital
    185’102.68 → 196’676.75
    Shares
    18’510’268 → 19’667’675
    New shares, % of post-step shares
    5.9% (1’157’407 new)

    Aktienkapital neu: CHF 196'676.75 [bisher: CHF 185'102.68]. Liberierung Aktienkapital neu: CHF 196'676.75 [bisher: CHF 185'102.68]. Aktien neu: 19'667'675 Namenaktien zu CHF 0.01 [bisher: 18'510'268 Namenaktien zu CHF 0.01].

    From the SHAB entry · German original, person names removed · not an official copy · full entry ↗
    • The increase is an odd amount in small-nominal shares, as priced rounds usually are.+1.0
    • The company was founded less than six years before this capital increase.+0.5
    • The company's purpose describes technology or life-sciences development.+0.5

    Classifier score 0.75 · likely-financing threshold 0.60 · not a calibrated probability

    SHAB HR02-1006572851 ↗

Published by 8 Oct 2026